Cargando…
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Over 20 years ago, orexin neuropeptides (Orexin-A/hypocretin-1 and Orexin-B/hypocretins-2) produced from the same precursor in hypothalamus were identified. These two neurotransmitters and their receptors (OX1R and OX1R), present in the central and peripheral nervous system, play a major role in wak...
Autores principales: | Alain, Couvineau, Pascal, Nicole, Valérie, Gratio, Thierry, Voisin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398691/ https://www.ncbi.nlm.nih.gov/pubmed/34443437 http://dx.doi.org/10.3390/molecules26164849 |
Ejemplares similares
-
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
por: Couvineau, Alain, et al.
Publicado: (2018) -
The Orexin receptors: Structural and anti-tumoral properties
por: Couvineau, Alain, et al.
Publicado: (2022) -
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
por: Couvineau, Alain, et al.
Publicado: (2021) -
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
por: Couvineau, Alain, et al.
Publicado: (2019) -
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
por: Dayot, Stéphanie, et al.
Publicado: (2018)